- Investors say United HealthCare, the third largest public healthcare company in the world by market value, shifted away from its much maligned practice of denying treatment and claims, without publicly disclosing the impact on company profits.
- Faller v. UnitedHealth Group Incorporated (1:25-cv-03799) (courtlistener.com)
This is a class action on behalf of persons or entities who purchased publicly traded UnitedHealth securities between December 3, 2024 and April 16, 2025, inclusive (the “Class Period”). Plaintiff seeks to recover compensable damages caused by Defendants’ violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
- Faller v. UnitedHealth Group Incorporated (1:25-cv-03799) (courtlistener.com)
This is a class action on behalf of persons or entities who purchased publicly traded UnitedHealth securities between December 3, 2024 and April 16, 2025, inclusive (the “Class Period”). Plaintiff seeks to recover compensable damages caused by Defendants’ violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
- UnitedHealth Group Announces Leadership Transition (unitedhealthgroup.com)
UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty’s decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company’s Board of Directors and Witty will serve as a senior adviser to Hemsley.
UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead, and return to our long-term earnings growth rate target of 13 to 16%.
Andrew Witty, chief executive officer of UnitedHealth Group
